NCT05432349

Brief Summary

The Rett Syndrome Registry is a longitudinal observational study of individuals with MECP2 mutations and a diagnosis of Rett syndrome. Designed together with the IRSF Rett Syndrome Center of Excellence Network medical directors, this study collects data on the signs and symptoms of Rett syndrome as reported by the Rett syndrome experts and by the caregivers of individuals with Rett syndrome. This study will be used to develop consensus based guidelines for the care of your loved ones with Rett syndrome and to facilitate the development of better clinical trials and other aspects of the drug development path for Rett syndrome.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
26mo left

Started Aug 2022

Longer than P75 for all trials

Geographic Reach
1 country

18 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress64%
Aug 2022Jul 2028

First Submitted

Initial submission to the registry

April 5, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 27, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

August 2, 2022

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2028

Last Updated

January 11, 2023

Status Verified

January 1, 2023

Enrollment Period

4.9 years

First QC Date

April 5, 2022

Last Update Submit

January 9, 2023

Conditions

Keywords

Rett syndromeMECP2Neurodevelopmental disorderRegistryNatural History Study

Outcome Measures

Primary Outcomes (1)

  • Natural History

    To longitudinally evaluate the natural history of patients with mutations on the MECP2 gene, estimating and defining their clinical spectrum (e.g. disease course and complications of disease).

    5 years

Eligibility Criteria

Age0 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population is males and females of all ages with a loss of function alteration of the MECP2 gene, most commonly resulting in Rett syndrome.

You may qualify if:

  • Male or female with a pathologic loss of function alteration of MECP2

You may not qualify if:

  • Male or female with a gain of function alteration of MECP2, including those with MEPC2 duplication or triplication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (18)

University of Alabama

Birmingham, Alabama, 35233, United States

RECRUITING

Children's Hospital Los Angeles

Los Angeles, California, 90027, United States

NOT YET RECRUITING

UCSF Benioff Children's Hospital

Oakland, California, 94609, United States

RECRUITING

Children's Hospital Colorado

Denver, Colorado, 80045, United States

RECRUITING

Rush University Medical Center

Chicago, Illinois, 60612, United States

RECRUITING

Kennedy Krieger Institute

Baltimore, Maryland, 21205, United States

RECRUITING

Boston Children's Hospital

Boston, Massachusetts, 02115, United States

RECRUITING

Gillette Children's Specialty Healthcare

Saint Paul, Minnesota, 55101, United States

RECRUITING

Washington University in St. Louis

St Louis, Missouri, 63110, United States

RECRUITING

The Children's Hospital at Montefiore

The Bronx, New York, 10467, United States

RECRUITING

The University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27517, United States

NOT YET RECRUITING

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, 45229, United States

NOT YET RECRUITING

Nationwide Children's Hospital

Columbus, Ohio, 43205, United States

NOT YET RECRUITING

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104, United States

RECRUITING

Greenwood Genetic Center

Greenwood, South Carolina, 29646, United States

RECRUITING

Vanderbilt Kennedy Center

Nashville, Tennessee, 37232, United States

RECRUITING

Children's Health

Dallas, Texas, 75207, United States

RECRUITING

Texas Children's Hospital

Houston, Texas, 77030, United States

RECRUITING

MeSH Terms

Conditions

Rett SyndromeRett Syndrome, AtypicalGenetic Diseases, InbornGenetic Diseases, X-LinkedIntellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesNeurodevelopmental Disorders

Condition Hierarchy (Ancestors)

X-Linked Intellectual DisabilityCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHeredodegenerative Disorders, Nervous SystemSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Central Study Contacts

Dominique C. Pichard, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2022

First Posted

June 27, 2022

Study Start

August 2, 2022

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2028

Last Updated

January 11, 2023

Record last verified: 2023-01

Locations